OR WAIT null SECS
June 30, 2025
Article
The CRL cited deficiencies previously identified at a third-party manufacturing vendor unrelated to OLC, and the Company plans to request a Type A meeting.
June 25, 2025
Video
From new data for potential IgAN treatments to the use of combination initiation therapy for type 2 diabetes and CKD, here are 5 key updates from the annual meeting.
June 22, 2025
A global study reveals that universal access to semaglutide could save 28 million lives and significantly reduce obesity and diabetes worldwide.
June 20, 2025
Investigators also noted the risk of Hb overshoot in patients switching from ESA to roxadustat, emphasizing the importance of monitoring Hb levels before and after treatment.
June 10, 2025
A recap of 3 Kidney Compass podcast episodes recorded at ERA 2025, including summaries and preview clips.
A recap of 5 studies to know from the ERA 2025 Congress, including expert perspectives.
With so many new medications ostensibly filling the niche typically occupied by ACE/ARBs, are the medications practically useful in a changed treatment landscape?
June 09, 2025
A recent meta-analysis reveals GLP-1 RAs significantly reduce adverse kidney outcomes, highlighting their potential in chronic kidney disease management.
June 08, 2025
A RaDaR analysis from ERA 2025 provides insight into predictors of disease progression, outcomes in patients with Alport syndrome.
June 07, 2025
Study findings highlight the potential utility of cardiac catheterization as a targeted intervention in pre-kidney transplant cardiac risk stratification.
